NCT07758309

Brief Summary

COVID-19 misinformation contributed to vaccine hesitancy and preventable illness. This record covers three sequential randomized studies (conducted in Canada and the United States, November-December 2020) testing whether a brief online game helps adults identify COVID-19 and vaccine misinformation. In the game, participants judged whether statements about COVID-19 or COVID-19 vaccines were true or false and immediately received the correct answer with a brief evidence-based explanation, delivered in a game-like format with points, ranks, and feedback. Study 1 (Canada, n = 2,018) randomized participants to complete the knowledge assessment either before playing the game or immediately after playing it. Studies 2 (U.S., n = 822) and 3 (U.S., n = 797) compared the game against the identical corrective content presented as plain text, for general COVID-19 misinformation and vaccine-specific misinformation, respectively. The hypothesis was that gamified corrective information produces more accurate knowledge than non-gamified information. The primary outcome was accuracy in identifying true and false claims; vaccination intention was a secondary outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,637

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2020

Completed
5.6 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
Last Updated

August 11, 2026

Status Verified

July 1, 2026

Enrollment Period

1 month

First QC Date

July 31, 2026

Last Update Submit

August 5, 2026

Conditions

Keywords

misinformationrefutationgamificationserious gameshealth educationvaccine hesitancyinfodemicbelief changedebunkingonline intervention

Outcome Measures

Primary Outcomes (1)

  • Mean Knowledge Accuracy Score

    Mean score across true/false misinformation items, ranging from 0 to 1, with higher scores indicating greater accuracy. Trial 1 included 6 items, Trial 2 included 19 items, and Trial 3 included 17 items. In Trials 1 and 2, "Unsure" responses received 0.5 points; Trial 3 used forced-choice true/false responses.

    Single session (Day 1). Assessed immediately post-intervention in all intervention and text-control arms; in Trial 1's assessment-first control arm, assessed at the start of the session before game exposure.

Secondary Outcomes (3)

  • Vaccination Intention Score - Trial 1

    Immediately post-intervention (single session, Day 1); control arm assessed at session start before game exposure.

  • Vaccination Intention Score - Trial 2

    Immediately post-intervention (single session, Day 1).

  • Vaccination Intention Score - Trial 3

    Baseline before randomization and immediately post-intervention during the single study session, Day 1.

Study Arms (6)

Trial 1: Assessment-First Control

OTHER

Completed the knowledge assessment before receiving the gamified refutation quiz (single session).

Behavioral: Gamified misinformation refutation quiz

Trial 1: Game

EXPERIMENTAL

Played the gamified refutation quiz using general COVID-19 items with immediate per-item feedback, followed by the post-intervention assessments.

Behavioral: Gamified misinformation refutation quiz

Trial 2: Text Control

ACTIVE COMPARATOR

Judged all general COVID-19 items, then received all refutational content as a single static text block without game elements, confirmed reading the text, and then completed the post-intervention assessments.

Behavioral: Refutational text (active control)

Trial 2: Game

EXPERIMENTAL

Played the gamified refutation quiz using general COVID-19 items with immediate per-item feedback, followed by the post-intervention assessments.

Behavioral: Gamified misinformation refutation quiz

Trial 3: Text Control

ACTIVE COMPARATOR

Judged all vaccine-specific items, then received all refutational content as a single static text block without game elements, confirmed reading the text, and then completed the post-intervention assessments.

Behavioral: Refutational text (active control)

Trial 3: Game

EXPERIMENTAL

Played the gamified refutation quiz using vaccine-specific items with immediate per-item feedback, followed by the post-intervention assessments.

Behavioral: Gamified misinformation refutation quiz

Interventions

Single-session online game: participants judge true/false statements about COVID-19 (Trials 1-2) or COVID-19 vaccines (Trial 3) and immediately after each response receive the correct answer with a brief evidence-based refutation, within a gamified interface (points, ranks, feedback). 6-19 knowledge items depending on trial.

Trial 1: Assessment-First ControlTrial 1: GameTrial 2: GameTrial 3: Game

Identical evidence-based refutational content presented as a single static text block without game elements or item-level feedback. Participants confirmed reading the text before completing the post-intervention assessments.

Trial 2: Text ControlTrial 3: Text Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 or older
  • Trial 1: Canadian residents residing outside Quebec, with internet access, able to complete the questionnaire in English
  • Trials 2-3: Amazon Mechanical Turk workers located in the United States, with a HIT approval rate of at least 95% and more than 100 approved HITs.

You may not qualify if:

  • Trial 1: employment in market research, advertising, media, or by a political party

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Online

Columbia, South Carolina, 29208, United States

Location

MeSH Terms

Conditions

COVID-19Vaccination HesitancyCommunicationHealth Education

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesVaccination RefusalTreatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehaviorAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health Care

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Three sequential, independently fielded two-arm parallel randomized trials under one protocol. Trial 1 (Canada): assessment before vs. assessment after gamified quiz (general COVID-19 misinformation). Trials 2-3 (U.S.): gamified quiz vs. identical content as static text (general COVID-19 and vaccine-specific misinformation, respectively). Participants were randomized only between the two arms of their respective trial and were never randomized among all six arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 31, 2026

First Posted

August 11, 2026

Study Start

November 20, 2020

Primary Completion

December 28, 2020

Study Completion

December 28, 2020

Last Updated

August 11, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Deidentified per-trial analysis-ready datasets and a data dictionary underlying published results will be available from the authors on reasonable request. Ethnicity is shared in grouped form and geographic region withheld to limit re-identification risk.

Shared Documents
ANALYTIC CODE
Time Frame
Beginning upon publication of trial results; no end date.
Access Criteria
Data shared with qualified researchers for verification or secondary analysis.

Locations